Korean J Med > Volume 86(2); 2014 > Article
The Korean Journal of Medicine 2014;86(2):152-161.
Published online February 1, 2014.
DOI: https://doi.org/10.3904/kjm.2014.86.2.152   
Clinical Features and Prognosis of Intraductal Papillary Mucinous Neoplasm of the Pancreas
Tae Hyeon Kim
Department of Internal Medicine, Wonkwang University College of Medicine, Iksan, Korea
췌관내 유두상점액종양의 임상적 특징 및 예후
김태현
원광대학교 의과대학 내과학교실
Correspondence: 
Tae Hyeon Kim, Tel: +82-63-859-2670, Fax: +82-63-855-2205, Email: kth@wonkwang.ac.kr
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Intraductal papillary mucinous neoplasm is frequently found recently and have recognized as precancerous lesions to pancreatic cancer that characterized by papillary growth of the ductal epithelium with rich mucin production and cystic dilatation of the main pancreatic duct and/or its branches. These tumors are asymptomatic and often multifocal. Preoperative differentiation between benign and malignant lesions is important to select the most appropriate treatment and to improve prognosis. Surgical resection is the treatment of choice to avoid malignant transformation when predictive factors for malignancy are present. These factors include mural nodule in the cyst, main pancreatic duct dilation, thick septum, cyst greater than 3 cm, atypias in the cyst fluid and the presence of symptoms. The follow-up of these patients who do not undergo surgical resection, is of great importance, since patients with IPMN appear to be at risk for pancreatic cancer. Patients who retain a portion of their pancreas following resection of an IPMN need to be followed up with periodic imaging to detect recurrences and metachronous lesions. (Korean J Med 2014;86:152-161)
Key Words: Intraductal papillary mucinous neoplasm; Pancreatic cancer; Surveillance
주제어: 췌관내유두상점액종양; 췌장암; 추적관리


TOOLS
METRICS Graph View
  • 1 Crossref
  •  0 Scopus
  • 3,388 View
  • 81 Download

Editorial Office
101-2501, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-2271-6791    Fax: +82-2-790-0993    E-mail: kaim@kams.or.kr                

Copyright © 2024 by The Korean Association of Internal Medicine.

Developed in M2PI

Close layer
prev next